Found: 12
Select item for more details and to access through your institution.
Dysfunctional Inhibitory Mechanisms in Locus Coeruleus Neurons of the Wistar Kyoto Rat.
- Published in:
- International Journal of Neuropsychopharmacology, 2015, v. 18, n. 7, p. 1, doi. 10.1093/ijnp/pyu122
- By:
- Publication type:
- Article
The role of NMDA receptor-dependent activity of noradrenergic neurons in attention, impulsivity and exploratory behaviors.
- Published in:
- Genes, Brain & Behavior, 2017, v. 16, n. 8, p. 812, doi. 10.1111/gbb.12383
- By:
- Publication type:
- Article
Peripheral induction of burst firing in locus coeruleus neurons by nicotine mediated via excitatory amino acids.
- Published in:
- Synapse, 1989, v. 4, n. 4, p. 313, doi. 10.1002/syn.890040407
- By:
- Publication type:
- Article
6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration.
- Published in:
- Psychopharmacology, 2014, v. 231, n. 9, p. 1913, doi. 10.1007/s00213-013-3333-0
- By:
- Publication type:
- Article
Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson’s Disease.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 5, p. 4511, doi. 10.1007/s12035-018-0979-y
- By:
- Publication type:
- Article
Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson’s Disease.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 1, p. 286, doi. 10.1007/s12035-017-0741-x
- By:
- Publication type:
- Article
Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson’s Disease.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 1, p. 201, doi. 10.1007/s12035-017-0733-x
- By:
- Publication type:
- Article
Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors.
- Published in:
- Molecular Neurobiology, 2017, v. 54, n. 10, p. 7722, doi. 10.1007/s12035-016-0244-1
- By:
- Publication type:
- Article
Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease-Effects of Nanoencapsulated Neurotrophic Factors Administration.
- Published in:
- Molecular Neurobiology, 2015, v. 52, n. 2, p. 846, doi. 10.1007/s12035-015-9234-y
- By:
- Publication type:
- Article
Pharmacological treatment of Parkinson’s disease: life beyond dopamine D2/D3 receptors?
- Published in:
- Journal of Neural Transmission, 2008, v. 115, n. 3, p. 431, doi. 10.1007/s00702-007-0852-z
- By:
- Publication type:
- Article